论文部分内容阅读
The U.S.Food and Drug Administration today approved Tresiba(insulin degludec injection)and Ryzodeg70/30(insulin degludec/insulin aspart injection)to improve blood sugar(glucose)control in adults with diabetes mellitus.According to the Centers for Disease Control and Prevention,approximately 21 million people in the United States have been diagnosed with diabetes.Over time,diabetes increases the risk of serious health complications,
The US Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec / insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus. Accredited to the Centers for Disease Control and Prevention, approximately 21 million people in the United States have been diagnosed with diabetes. Over time, diabetes increases the risk of serious health complications,